Surgical face masks worn by patients with multidrug-resistant tuberculosis: impact on infectivity of air on a hospital ward
- PMID: 22323300
- PMCID: PMC3359891
- DOI: 10.1164/rccm.201107-1190OC
Surgical face masks worn by patients with multidrug-resistant tuberculosis: impact on infectivity of air on a hospital ward
Abstract
Rationale: Drug-resistant tuberculosis transmission in hospitals threatens staff and patient health. Surgical face masks used by patients with tuberculosis (TB) are believed to reduce transmission but have not been rigorously tested.
Objectives: We sought to quantify the efficacy of surgical face masks when worn by patients with multidrug-resistant TB (MDR-TB).
Methods: Over 3 months, 17 patients with pulmonary MDR-TB occupied an MDR-TB ward in South Africa and wore face masks on alternate days. Ward air was exhausted to two identical chambers, each housing 90 pathogen-free guinea pigs that breathed ward air either when patients wore surgical face masks (intervention group) or when patients did not wear masks (control group). Efficacy was based on differences in guinea pig infections in each chamber.
Measurements and main results: Sixty-nine of 90 control guinea pigs (76.6%; 95% confidence interval [CI], 68-85%) became infected, compared with 36 of 90 intervention guinea pigs (40%; 95% CI, 31-51%), representing a 56% (95% CI, 33-70.5%) decreased risk of TB transmission when patients used masks.
Conclusions: Surgical face masks on patients with MDR-TB significantly reduced transmission and offer an adjunct measure for reducing TB transmission from infectious patients.
Figures
Comment in
-
Behind the mask: overdue evidence.Am J Respir Crit Care Med. 2012 May 15;185(10):1041-3. doi: 10.1164/rccm.201203-0548ED. Am J Respir Crit Care Med. 2012. PMID: 22589311 No abstract available.
References
-
- World Health Organization WHO report 2009 global tuberculosis control: epidemiology, strategy, financing. Geneva, Switzerland: World Health Organization; 2009
-
- World Health Organization WHO report 2010: multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response [Internet; accessed 2011 Jun 2]. Available from: http://www.Who.Int/tb/publications/2010/en/index.Html
-
- Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368:1575–1580 - PubMed
-
- O'Donnell MR, Jarand J, Loveday M, Padayatchi N, Zelnick J, Werner L, Naidoo K, Master I, Osburn G, Kvasnovsky C, et al. High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers. Ann Intern Med 2010;153:516–522 - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
